Advanced search
Publication Cover
Autoimmunity Volume 38, 2005 - Issue 2
Submit an article Journal homepage
61
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Hypothesis
Concurrent HLA-related response factors mediate recombinant hepatitis B vaccine major adverse events

J. D. Miller Greater Portland Pediatric Associates, Maine Medical Center, Portland, ME, USA
&
L. H. Whitehair McDonnell Douglas Corp. (ret), St. Louis, MO, USACorrespondence[email protected]
Pages 181-194 | Received 11 Feb 2005, Accepted 24 Feb 2005, Published online: 07 Jul 2009

References

  • Incao P. Testimony to Ohio House of Representatives 1999 Mar 1. Available: www.garynull.com/Documents/niin/ incao_hepatitis_b_vaccination_te.htm via the INTERNET. Accessed: Jan 25
  • Centers for Disease Control and Prevention., Vaccine Safety Datalink (VSD) Project, Completed and Current Studies, December, 2000—November, 2003—[cited 2005 Jan 12]; Available from: http//www.cdc.gov/nip/vacsafe/vsd/research. htm
  • Yell JA, Mbuagbaw J, Burge SM. Cutaneous manifestations of systemic lupus erythematosus. Br J Dermatol 1996; 135:355–362.
  • Lucchinetti CF, Kiers L, O'Duffy A, Gomez MR, Cross S, Leavitt JA, O'Brien P, Rodriguez M. Risk factors fordeveloping multiple sclerosis after childhood optic neuritis. Neurology 1997;49:1413–1418.
  • Mineta M, Tanimura M, Tana T, Yssel H, Kashiwagi S, Sasazuki T. Contribution of HLA class I and class II alleles to the regulation of antibody production to hepatitis B surface antigen in humans. Int Immunol 1996;8:525–531.
  • Caillat-Zucman S, Gimenez JJ, Wambergue F, Albouze G, Lebkiri B, Naret C, Moynot A, Jungers P, Bach JF, Distinct HLA class II. alleles determine antibody response to vaccination with hepatitis B surface antigen. Kidney hit 1998;53:1626–1630.
  • Hohler T, Meyer CU, Notghi A, Stradmann-Bellinghausen B, Schneider PM, Starke R, Zepp F, Sanger R, Clemens R, Meyer zum Buschenfelde KH, Rittner C. The influence of major histocompatibility complex class II genes and T-cell Vbeta repertoire on response to immunization with HBsAg. Hum Immunol 1998;59:212–218.
  • Egea E, Iglesias A, Salazar M, Morimoto C, Kruskall MS, Awdeh Z, Schlossman SF, Alper CA, Yunis EJ. The cellular basis for lack of antibody response to hepatitis B vaccine in humans. J Exp Med 1991;173:531–538.
  • Schuenke KW, Cook RG, Rich RR. Binding specificity of a class II-restricted hepatitis B epitope by DR molecules from responder and nonresponder vaccine recipients. Hum Immunol 1998;59:783–793.
  • Lango-Warensjo A, Cardell K, Lindblom B. Haplotypes comprising subtypes of the DQB1*06 allele direct the antibody response after immunisation with hepatitis B surface antigen. Tissue Antigens 1998;52: 374–380.
  • Nayersina R, Fowler P, Guilhot S, Missale G, Cerny A, Schilcht HJ, Vitiello A, Chesnut R, Person JL, Redeker AG, et al. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. J Immunol 1993;150:4659–4671.
  • Usonis V, Kuhnl P, Brede HD, Doerr HW. Humoral immune response after hepatitis-B-vaccination: Kinetics of anti-HBs antibodies and demonstration of HLA antigens. Zentralb Bakteriol Mikrobiol Hyg [A] 1986;262:377–384.
  • Thio CL, Thomas DL, Karacki P, Gao X, Marti D, Kaslow RA, Goedert jj, Hilgartner M, Strathdee SA, Duggal P, O'Brien SJ, Astemborski J, Carrington M. Comprehensive analysis of class I and class II HLA antigens and chronic hepatitis B virus infection. J Virol 2003;77:12083–12087.
  • Achiron LR. Postinfectious hepatitis B optic neuritis. Optom Vis Sci 1994;71:53–56.
  • Heermann KH, Gerlich WH. Immunology of hepatitis B infections. Rheumatol Int 1989;9:167–173.
  • Taneja V, Mehra NK, Chandershekaran AN, Ahuja RK, Singh YN, Malaviya AN. HLA-DR4-DQw8, but not DR4-DQw7 haplotypes occur in Indian patients with rheumatoid arthritis. Rheumatol hit 1992;11:251–255.
  • Truedsson L, Sturfelt G, Johansen P, Nived O, Thuresson B. Sharing of MHC haplotypes among patients with systemic lupus erythematosus from unrelated Caucasian multicase families: Disease associations with the extended haplotype [HLA-B8, SC01, DR17]. J Rheumatol 1995;22: 1852–1861.
  • Davatchi F, Nikbin B, Ala F. Histocompatibility antigens (HLA) in rheumatic diseases in Iran. J Rheumatol Suppl 1977;3:36–38.
  • Davies ML, Young SP, Welsh K, Bunce M, Wordsworth BP, Davies KA, Wagenknecht DR, Taylor E, Gordon C, Jobson S, Briggs D, Bowman SJ. Immune response to native beta(2)-glycoprotein I in patients with systemic lupus erythematosus and the antiphospholipid syndrome. Rheumatology(Oxford) 2002;41:395–400.
  • Arnett FC, Thiagarajan P, Ahn C, Reveille JD. Associations of anti-beta2-glycoprotein I autoantibodies with HLA class II antigens in three ethnic groups. Arthritis Rheum 1999; 42:268–274.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.